These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 28182987

  • 21. Synthesis, characterization and antitumor activity of polymeric copper(II) complexes with thiosemicarbazones of 3-methyl-5-oxo-1-phenyl-3-pyrazolin-4-carboxaldehyde and 5-oxo-3-phenyl-3-pyrazolin-4-carboxaldehyde.
    Leovac VM, Bogdanović GA, Jovanović LS, Joksović L, Marković V, Joksović MD, Denčić SM, Isaković A, Marković I, Heinemann FW, Trifunović S, Đalović I.
    J Inorg Biochem; 2011 Nov; 105(11):1413-21. PubMed ID: 21955843
    [Abstract] [Full Text] [Related]

  • 22. 8-Hydroxyquinoline derived p-halo N4-phenyl substituted thiosemicarbazones: Crystal structures, spectral characterization and in vitro cytotoxic studies of their Co(III), Ni(II) and Cu(II) complexes.
    Kotian A, Kamat V, Naik K, Kokare DG, Kumara K, Neratur KL, Kumbar V, Bhat K, Revankar VK.
    Bioorg Chem; 2021 Jul; 112():104962. PubMed ID: 33992968
    [Abstract] [Full Text] [Related]

  • 23. Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH).
    Qin QP, Liu YC, Wang HL, Qin JL, Cheng FJ, Tang SF, Liang H.
    Metallomics; 2015 Jul; 7(7):1124-36. PubMed ID: 25904543
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparative evaluation of the structure and antitumor mechanism of mononuclear and trinucleated thiosemicarbazone Cu(II) complexes.
    Zheng Y, Wei K, Gao Y, Zhou Z, Zheng X, Li J, Qi J.
    J Inorg Biochem; 2023 Mar; 240():112116. PubMed ID: 36592511
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Influence of Complexation of Thiosemicarbazone Derivatives with Cu (II) Ions on Their Antitumor Activity against Melanoma Cells.
    Pitucha M, Korga-Plewko A, Czylkowska A, Rogalewicz B, Drozd M, Iwan M, Kubik J, Humeniuk E, Adamczuk G, Karczmarzyk Z, Fornal E, Wysocki W, Bartnik P.
    Int J Mol Sci; 2021 Mar 18; 22(6):. PubMed ID: 33803618
    [Abstract] [Full Text] [Related]

  • 31. Cytotoxic activity, albumin and DNA binding of new copper(II) complexes with chalcone-derived thiosemicarbazones.
    Da Silva JG, Recio Despaigne AA, Louro SR, Bandeira CC, Souza-Fagundes EM, Beraldo H.
    Eur J Med Chem; 2013 Jul 18; 65():415-26. PubMed ID: 23747809
    [Abstract] [Full Text] [Related]

  • 32. Mixed-ligand Cu(II) hydrazone complexes designed to enhance anticancer activity.
    Mo Q, Deng J, Liu Y, Huang G, Li Z, Yu P, Gou Y, Yang F.
    Eur J Med Chem; 2018 Aug 05; 156():368-380. PubMed ID: 30015073
    [Abstract] [Full Text] [Related]

  • 33. Thiosemicarbazone N-Heterocyclic Cu(II) complexes inducing nuclei DNA and mitochondria damage in hepatocellular carcinoma cells.
    Zhang S, Zhao J, Guo Y, Hu J, Chen X, Ruan H, Cao T, Hou H.
    J Inorg Biochem; 2022 Nov 05; 236():111964. PubMed ID: 36027842
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.